• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路易体痴呆的患病率和发病率:一项系统综述。

The Prevalence and Incidence of Dementia with Lewy Bodies: a Systematic Review.

作者信息

Hogan David B, Fiest Kirsten M, Roberts Jodie I, Maxwell Colleen J, Dykeman Jonathan, Pringsheim Tamara, Steeves Thomas, Smith Eric E, Pearson Dawn, Jetté Nathalie

机构信息

1Brenda Strafford Chair in Geriatric Medicine,University of Calgary,Calgary,Alberta,Canada.

2Hotchkiss Brain Institute,University of Calgary,Calgary,Alberta,Canada.

出版信息

Can J Neurol Sci. 2016 Apr;43 Suppl 1:S83-95. doi: 10.1017/cjn.2016.2.

DOI:10.1017/cjn.2016.2
PMID:27307129
Abstract

BACKGROUND

Population-based prevalence and incidence studies are essential for understanding the societal burden of dementia with Lewy bodies (DLB).

METHODS

The MEDLINE and EMBASE databases were searched to identify publications addressing the incidence and/or prevalence of DLB. References of included articles and prior systematic reviews were searched for additional studies. Two reviewers screened all abstracts and full-text reviews, abstracted data and performed quality assessments.

RESULTS

Twenty-two studies were included. Incidence rates ranged from 0.5 to 1.6 per 1000 person-years. DLB accounted for 3.2-7.1% of all dementia cases in the incidence studies. Point and period prevalence estimates ranged from 0.02 to 63.5 per 1000 persons. Increasing prevalence estimates were reported with increasing age. DLB accounted for from 0.3 to 24.4% of all cases of dementia in the prevalence studies.

CONCLUSIONS

DLB becomes more common with increasing age and accounts for about 5% of all dementia cases in older populations.

摘要

背景

基于人群的患病率和发病率研究对于理解路易体痴呆(DLB)的社会负担至关重要。

方法

检索MEDLINE和EMBASE数据库,以识别涉及DLB发病率和/或患病率的出版物。检索纳入文章的参考文献和先前的系统评价,以寻找其他研究。两名审阅者筛选所有摘要和全文综述,提取数据并进行质量评估。

结果

纳入22项研究。发病率范围为每1000人年0.5至1.6例。在发病率研究中,DLB占所有痴呆病例的3.2 - 7.1%。时点患病率和期间患病率估计范围为每1000人0.02至63.5例。随着年龄增长,患病率估计值增加。在患病率研究中,DLB占所有痴呆病例的0.3至24.4%。

结论

DLB随着年龄增长变得更加常见,在老年人群中约占所有痴呆病例的5%。

相似文献

1
The Prevalence and Incidence of Dementia with Lewy Bodies: a Systematic Review.路易体痴呆的患病率和发病率:一项系统综述。
Can J Neurol Sci. 2016 Apr;43 Suppl 1:S83-95. doi: 10.1017/cjn.2016.2.
2
A systematic review of prevalence and incidence studies of dementia with Lewy bodies.路易体痴呆患病率和发病率研究的系统评价
Age Ageing. 2005 Nov;34(6):561-6. doi: 10.1093/ageing/afi190.
3
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
4
Cholinesterase inhibitors for dementia with Lewy bodies.用于路易体痴呆的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2003;2003(3):CD003672. doi: 10.1002/14651858.CD003672.
5
The Prevalence and Incidence of Frontotemporal Dementia: a Systematic Review.额颞叶痴呆的患病率和发病率:一项系统综述
Can J Neurol Sci. 2016 Apr;43 Suppl 1:S96-S109. doi: 10.1017/cjn.2016.25.
6
Prevalence, timing and characteristics of delirium preceding dementia with Lewy bodies: a retrospective case series.路易体痴呆之前谵妄的患病率、发生时间及特征:一项回顾性病例系列研究
J Neurol. 2025 Jun 21;272(7):471. doi: 10.1007/s00415-025-13193-y.
7
The Prevalence and Incidence of Dementia: a Systematic Review and Meta-analysis.痴呆症的患病率和发病率:一项系统评价与荟萃分析
Can J Neurol Sci. 2016 Apr;43 Suppl 1:S3-S50. doi: 10.1017/cjn.2016.18.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia.系统评价和荟萃分析表明,路易体痴呆是一种视知觉和注意-执行功能型痴呆。
Dement Geriatr Cogn Disord. 2003;16(4):229-37. doi: 10.1159/000072807.
10
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.

引用本文的文献

1
Regional associations between cerebrovascular disease and cholinergic white matter pathways in the Lewy body continuum.路易体连续体中脑血管疾病与胆碱能白质通路之间的区域关联。
NPJ Parkinsons Dis. 2025 Aug 21;11(1):250. doi: 10.1038/s41531-025-01118-5.
2
Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein.路易体痴呆:探索淀粉样β蛋白、tau蛋白和α-突触核蛋白的生物标志物及致病相互作用
Mol Neurodegener. 2025 Aug 12;20(1):90. doi: 10.1186/s13024-025-00879-0.
3
Risk factors and predictors for Lewy body dementia: a systematic review.
路易体痴呆的风险因素和预测因素:一项系统综述。
NPJ Dement. 2025;1(1):20. doi: 10.1038/s44400-025-00022-2. Epub 2025 Aug 4.
4
A Blood Screening Test for Dementia with Lewy Bodies for Primary Care.用于基层医疗的路易体痴呆血液筛查试验
J Alzheimers Dis Parkinsonism. 2023;13(6). Epub 2023 Dec 4.
5
Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies.路易体痴呆显性和前驱期生物学框架的意义与机遇
Alzheimers Dement. 2025 Jul;21(7):e70470. doi: 10.1002/alz.70470.
6
Pharmacy Dispensing Records to Describe and Evaluate the Use of Acetylcholinesterase Inhibitors Among Swedish Antipsychotic Drug Users with Symptoms of Lewy Body Dementia.药房配药记录:描述和评估瑞典患有路易体痴呆症状的抗精神病药物使用者中乙酰胆碱酯酶抑制剂的使用情况。
Drugs Real World Outcomes. 2025 May 31. doi: 10.1007/s40801-025-00501-1.
7
Genetic risk and plasma biomarkers of dementia with Lewy bodies in a Chinese population.中国人群中路易体痴呆的遗传风险和血浆生物标志物
NPJ Parkinsons Dis. 2025 May 15;11(1):128. doi: 10.1038/s41531-025-00988-z.
8
Examining the lived experience of dementia with Lewy bodies through qualitative research: A systematic review.通过定性研究审视路易体痴呆的生活经历:一项系统综述。
Alzheimers Dement. 2025 May;21(5):e70217. doi: 10.1002/alz.70217.
9
The potential of brain organoids in addressing the heterogeneity of synucleinopathies.脑类器官在解决突触核蛋白病异质性方面的潜力。
Cell Mol Life Sci. 2025 Apr 28;82(1):188. doi: 10.1007/s00018-025-05686-w.
10
Research models to study lewy body dementia.用于研究路易体痴呆的研究模型。
Mol Neurodegener. 2025 Apr 23;20(1):46. doi: 10.1186/s13024-025-00837-w.